TNL Mediagene announced its financial and operational results for the fiscal year ended December 31, 2024, on May 1, 2025. Consolidated revenue reached $48.5 million, marking a 35.3% increase over FY2023's $35.8 million.
Gross profit rose to $17.7 million, a 40.2% increase from $12.7 million in FY2023, resulting in a gross margin of 36.6%. Adjusted EBITDA improved to negative $0.9 million from negative $1.0 million in FY2023, nearing break-even.
However, the company reported a net income of negative $85.00 million, a significant increase from negative $0.80 million in FY2023. Operating cash flow remained negative at $10.21 million, and free cash flow was negative $10.58 million.
As of December 2024, cash and cash equivalents stood at $3.65 million, with total liabilities of $56.51 million and current liabilities of $32.99 million. The current ratio of 0.54 indicates a tight liquidity position, and a Z-score of -3.12 suggests an increased risk of bankruptcy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.